Abstract:Ethnopharmacological relevance Ginkgo biloba L. (Ginkgoaceae), a traditional Chinese medicine, has been applied for thousands of years for the treatment of cardio-cerebral vascular diseases in China. It is written in Compendium of Materia Medica that Ginkgo has the property of "dispersing poison", which is now referred to as anti-inflammatory and antioxidant. Ginkgolides are important active ingredients in Ginkgo biloba leaves and ginkgolide injection has been frequently applied in clinical practice for the treatment of ischemic stroke. However, few studies have explored the effect and mechanism of ginkgolide C (GC) with anti-inflammatory activity in cerebral ischemia/reperfusion injury (CI/RI). Aim of the study The present study aimed to demonstrate whether GC was capable of attenuating CI/RI. Furthermore, the anti-inflammatory effect of GC in CI/RI was explored around the CD40/NF-κB pathway. Materials and methods In vivo , middle cerebral artery occlusion/reperfusion (MCAO/R) model was established in rats. The neuroprotective effect of GC was assessed by neurological scores, cerebral infarct rate, microvessel ultrastructure, blood-brain barrier (BBB) integrity, brain edema, neutrophil infiltration, and levels of TNF-α, IL-1β, IL-6, ICAM-1, VCAM-1, and iNOS. In vitro , rat brain microvessel endothelial cells (rBMECs) were preincubated in GC before hypoxia/reoxygenation (H/R) culture. The cell viability, levels of CD40, ICAM-1, MMP-9, TNF-α, IL-1β, and IL-6, and activation of NF-κB pathway were examined. In addition, the anti-inflammatory effect of GC was also investigated by silencing CD40 gene in rBMECs. Results GC attenuated CI/RI as demonstrated by decreasing neurological scores, reducing cerebral infarct rate, improving microvessel ultrastructural features, ameliorating BBB disruption, attenuating brain edema, inhibiting MPO activity, and downregulating levels of TNF-α, IL-1β, IL-6, ICAM-1, VCAM-1, and iNOS. Coherently, in rBMECs exposed to H/R GC enhanced cell viability and downregulated levels of ICAM-1, MMP-9, TNF-α, IL-1β, and IL-6. Furthermore, GC suppressed CD40 overexpression and hindered translocation of NF-κB p65 from the cytosol to the nucleus, phosphorylation of IκB-α, and activation of IKK-β in H/R rBMECs. However, GC failed to protect rBMECs from H/R-induced inflammatory impairments and suppress activation of NF-κB pathway when CD40 gene was silenced. Conclusions GC attenuates cerebral ischemia/reperfusion-induced inflammatory impairments by suppressing CD40/NF-κB pathway, which may provide an available therapeutic drug for CI/RI.

Ginkgolide B Protects Human Pulmonary Alveolar Epithelial A549 Cells from Lipopolysaccharide‐induced Inflammatory Responses by Reducing TRIM37‐mediated NF‐κB Activation

Ginkgolide B Reduces Neuronal Cell Apoptosis in the Hemorrhagic Rat Brain: Possible Involvement of Toll-like Receptor 4/nuclear Factor-Kappa B Pathway.

EGB1212 Post-Treatment Ameliorates Hippocampal CA1 Neuronal Death and Memory Impairment Induced by Transient Global Cerebral Ischemia/reperfusion.

Ginkgolide B Functions As a Determinant Constituent of Ginkgolides in Alleviating Lipopolysaccharide-Induced Lung Injury

Ginkgolide B Protects Against Ischemic Stroke Via Modulating Microglia Polarization in Mice

The Protective Effect of Injection of Ginkgo Biloba Leave Extract on Mediators of Inflammation in Rats with Experimental Acute Lung Injury

Ginkgo Diterpene Lactones Inhibit Cerebral Ischemia/reperfusion Induced Inflammatory Response in Astrocytes Via TLR4/NF-κB Pathway in Rats.

Inhibition of NF-κB Activation is Associated with Anti-Inflammatory and Anti-Apoptotic Effects of Ginkgolide B in a Mouse Model of Cerebral Ischemia/reperfusion Injury

The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia.

1,2,3,4,6-O-Pentagalloylglucose Protects against Acute Lung Injury by Activating the AMPK/PI3K/Akt/Nrf2 Pathway

Oral Administration of Ginkgolide B Alleviates Hypoxia-Induced Neuronal Damage in Rat Hippocampus by Inhibiting Oxidative Stress and Apoptosis

Hmgb1-Triggered Inflammation Inhibition Of Notoginseng Leaf Triterpenes Against Cerebral Ischemia And Reperfusion Injury Via Mapk And Nf-Kappa B Signaling Pathways

Ginkgolide C attenuates lipopolysaccharide‑induced acute lung injury by inhibiting inflammation via regulating the CD40/NF‑κB signaling pathway

Exposure-Response Analysis and Mechanism of Ginkgolide B’s Neuroprotective Effect in Acute Cerebral Ischemia/Reperfusion Stage in Rat

Brain-targeted Ginkgolide B-modified Carbonized Polymer Dots for Alleviating Cerebral Ischemia Reperfusion Injury

HMGB1-triggered inflammation inhibition of notoginseng leaf triterpenes against cerebral ischemia and reperfusion injury via MAPK and NF-κB signaling pathways

Platelet Membrane-Encapsulated Ginkgolide B Biomimetic Nanoparticles for the Treatment of Ischemic Stroke

Ginkgolide B Blocks Vascular Remodeling after Vascular Injury via Regulating Tgf β 1/Smad Signaling Pathway

Neuroprotective effects of Ginkgo biloba extract and Ginkgolide B against oxygen–glucose deprivation/reoxygenation and glucose injury in a new in vitro multicellular network model

Antioxidant effects of ginkgolides and bilobalide against cerebral ischemia injury by activating the Akt/Nrf2 pathway in vitro and in vivo

Ginkgolide C attenuates cerebral ischemia/reperfusion-induced inflammatory impairments by suppressing CD40/NF-κB pathway